A multidisciplinary research team at Vanderbilt University and Vanderbilt University Medical Center has discovered a new way to kill a tumor by disrupting its acidic microenvironment without harming normal tissue.

Vanderbilt researchers are working to better design immune therapies that attack tumors without also attacking healthy normal tissue in patients.

Vanderbilts James E. Crowe Jr MD and Neil Osheroff PhD are among 12 individuals honored by the Association of American Medical Colleges during its 2023 Awards Recognition Event.

A multidisciplinary team of investigators has received a 2023 Endeavor Award from The Mark Foundation for Cancer Research to support four closely linked projects exploring the fundamental mechanisms that drive the obesity-cancer connection

Nancy Cox PhD director of the Vanderbilt Genetics Institute is the recipient of the 2023 ASHG Leadership Award from the American Society of Human Genetics.

Fluorescent nanoparticles clearly identified colonic adenomas precursors to colorectal cancer in mice and the formulation should translate to clinical use in humans.

An international coalition of biomedical researchers co-led by Vanderbilts Alexander Bick MD PhD has determined a new way to measure the growth rate of precancerous clones of blood stem cells that one day could help doctors lower their patients risk of blood cancer.